Company / Operating Income per Share
Twist Bioscience Corp Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.28
FY2025
5-year range
-$4.36 / -$2.28
FY2021-FY2025
Trend
+40.1%
vs FY2024
Sector context
#119 of 199
Health Care
What the data says
At $-2.28, Twist Bioscience Corp's operating income per share ranks #119 of 199 in the Health Care sector. Operating Income per Share has increased for 3 consecutive years, from $-4.36 in FY2022 to $-2.28 in FY2025.
Based on SEC 10-K filings.
-2.28 in FY2025.
Improved from $-3.82 to $-2.28 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#119 of 199 in Health CareTop 60% of 199This company -$2.28 Sector average -$3.34
▼
+31.7% above sector average
Key checks
Key Insights
- Twist Bioscience Corp's operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 40.1% year-over-year.
- Ranks #119 out of 199 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.28 | +40.1% |
| FY2024 | -$3.81 | +0.3% |
| FY2023 | -$3.82 | +12.4% |
| FY2022 | -$4.36 | -37.7% |
| FY2021 | -$3.17 | +11.4% |
| FY2020 | -$3.57 | +9.8% |
| FY2019 | -$3.96 | +100.0% |
| FY2018 | -$25262.80 | -104634899.0% |
| FY2017 | -$0.02 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026